PRIMARIUS(SH:688206) Xuan Gu Bao·2025-07-24 11:55Suspension and Resumption - Helen Piano's actual controller plans to transfer 23.83% of shares, and the stock will resume trading [1] - Yuanli Co. intends to acquire 100% equity of Fujian Tongsheng New Materials Technology Co., and the stock will resume trading [2] - Space Technology's controlling shareholder is planning a change in company control, leading to stock suspension [2] Capital Increase and Mergers - Fute Technology plans to raise no more than 528 million yuan through a private placement for projects related to core components of new energy vehicles and to supplement working capital [3] - Angel Yeast intends to acquire 55% equity of Shengtong Sugar Industry for a transaction amount of 506 million yuan [3] Share Transfer and Buyback - Saiwei Microelectronics' shareholder Wuyuefeng Investment and its concerted parties plan to transfer 18% of the company's shares [4] - Gao Neng Environment plans to use 100 million to 150 million yuan to repurchase company shares [5] Daily Operations and External Investments - Heng Rui Pharmaceutical's HRS-1893 tablets have received approval for clinical trials [6] - Gai Lun Electronics signed a strategic cooperation framework agreement with Shanghai Guotou and Shanghai Xinhe Chuang to promote comprehensive cooperation in the EDA industry [6] - Sanofi Guojian's licensing agreement with Pfizer for the 707 project has officially come into effect [7] - Yongli Co. acquired 22.75% equity of Yuli Pu Intelligent Equipment Manufacturing Co. [8] - Sanyangma's subsidiary Zhiren Technology signed a product procurement contract with a domestic automotive parts company for exclusive supply of sensor products [8] - Kaichuang International's wholly-owned subsidiary signed two shipbuilding contracts with Fujian Mawei Shipbuilding Co., with a price of 184 million yuan per ship [8] - Hengtong Optic-Electric received project award notices or signed project contracts, confirming a total bid amount of 1.509 billion yuan for domestic and international marine energy projects [8] Performance Changes - Zhimingda's net profit for the first half of 2025 is expected to be 38.298 million yuan, a year-on-year increase of 2147.93% [9] - Sainuo Medical expects a net profit of 13.84 million yuan for the first half of 2025, a year-on-year increase of 296.54%, mainly due to significant sales growth of two coronary stent products and coronary balloon products entering the centralized procurement range [9] - Zheshang Securities reported a net profit of 1.149 billion yuan for the first half of the year, a year-on-year increase of 46.54% [9]